Current Status and Alturas’ Ongoing Response to COVID-19
Updated 20JUL2020


Scientist Focus: Jennifer Zimmer, Ph.D.


Alturas Laboratory Director Jennifer Zimmer

Jennifer Zimmer, Ph.D. has been with Alturas Analytics since 2005. She has a vast background in bioanalytical as well as pharmacological science. As Laboratory Director, Dr. Zimmer is responsible for the overall operation and technical oversight of producing quality assays, generation of data and reports of the highest integrity and adapting to the changing landscape of the industry. She is an active participant in the Global CRO Council but is most proud of mentoring a team of scientists to be successful contributors in the bioanalytical industry.   

Dr. Zimmer received her B.A. degree in English and Zoology from the University of Idaho and her Ph.D. in Pharmacology from the University of Colorado Health Sciences Center.

What is the most rewarding part of your job?

Getting to see the impact that the novel compounds that we help analyze can have on the quality of life for patients. Even though our piece of the drug development process is a small one, it is really neat to see that the work we do at Alturas has a real benefit.

What accomplishments are you most proud of?

I am proud of how we have developed our training program to help us really build our team here at Alturas. The senior members of the team have worked together to make our training program build from the bottom up, which allows for a more seamless process and to helps all of our newer employees to be as successful as possible.

 What is the most challenging aspect of your job?

The ever-shifting timelines of drug development. This is also sometimes a fun challenge to see how we can best arrange timelines to make sure that we meet all of our sponsor’s deadlines.